A Statistical Brief from AHRQ examines certain trends in costs of retail drugs.
Read More
A study in the Journal of the American Medical Association Network Open finds savings and no harm from using a single-source approach to medical device procurement.
Read More
Medical genetic testing management company Invitae invites Clear Genetics to become part of the family, acquiring the maker of a chatbot to help consumers navigate genetic testing, for about $50 million.
https://ir.invitae.com/news-and-events/press-releases/press-release-details/2019/Invitae-to-Acquire-Clear-Genetics/default.aspxAccording to an article in Health Affairs, adding a cost-sharing free annual wellness visit to the Medicare benefits hasn't done much for better health.
Read More
A viewpoint in the Journal of the American Medical Association addresses the failure of the extensive set of quality improvement initiated by policymakers in the last decade.
Read More
Medopad, which does something related to gathering health information from wearables, pads its bank account with $25 in new capital, apparently raised at a valuation of around $200 million. There is too much capital and when there is, it does stupid stuff.
https://techcrunch.com/2019/11/05/medopad-raises-25m-led-by-bayer-to-develop-biomarkers-tracked-via-apps-and-wearables/In a short-lived announcement, Human Longevity births a fresh $30 million in capital to support the company's business of combining information to help assess individual's health, etc.
https://www.humanlongevity.com/human-longevity-closes-30-million-financing-from-emerging-technology-partners-and-other-leading-healthcare-investors-to-renew-its-commitment-to-longevity-and-precision-health/Research in the Journal of the American Medical Association examines treatment trends for end-of-life care in European ICUs.
Read More